{
  "run_id": "RUN_20260204_185220_21940d8e99aa",
  "timestamp": "2026-02-04T19:55:21.221721",
  "document": "Acquired-Lipodystrophy.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/test/Acquired-Lipodystrophy.pdf",
  "total_candidates": 56,
  "total_validated": 4,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "heuristics_counters": {
    "recovered_by_stats_whitelist": 0,
    "recovered_by_country_code": 0,
    "recovered_by_hyphen": 0,
    "recovered_by_direct_search": 0,
    "recovered_by_llm_sf_only": 3,
    "blacklisted_fp_count": 0,
    "common_word_rejected": 0,
    "context_rejected": 0,
    "form_filter_rejected": 1,
    "trial_id_excluded": 0
  },
  "abbreviations": [
    {
      "short_form": "APL",
      "long_form": "abductor pollicis longus",
      "confidence": 0.8,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "ch complications include an inability to break down glucose (glucose intolerance), elevated levels of triglycerides (a type of fat) in the blood (hypertriglyceridemia), and diabetes. Additional symptoms such as fat accumulation in the liver (fatty liver or hepatic steatosis) may also occur. AGL and APL generally affect women more than men, although this may be due in part to ascertainment bias because women tend to be more severely affected and more easily recognized. APL has been reported in approximately 250 individuals with a male to female ratio of 1:4. It has been reported in individuals of",
      "lexicon_source": "2025_08_abbreviation_general.json",
      "lexicon_ids": null
    },
    {
      "short_form": "HIV",
      "long_form": null,
      "confidence": 0.75,
      "field_type": "SHORT_FORM_ONLY",
      "page": 1,
      "context_text": "localized lipodystrophy, and high active antiretroviral induced lipodystrophy, which may develop in HIV-infected individuals undergoing a specific form of treatment. Onset of acquired forms of lipodystro",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    },
    {
      "short_form": "AGL",
      "long_form": null,
      "confidence": 0.75,
      "field_type": "SHORT_FORM_ONLY",
      "page": 1,
      "context_text": "l symptoms such as fat accumulation in the liver (fatty liver or hepatic steatosis) may also occur. AGL and APL generally affect women more than men, although this may be due in part to ascertainment bia",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    },
    {
      "short_form": "LD-HIV",
      "long_form": null,
      "confidence": 0.75,
      "field_type": "SHORT_FORM_ONLY",
      "page": 1,
      "context_text": "ly 100 individuals with a male to female ratio of 1:3. Most cases have been reported in Caucasians. LD-HIV is estimated to affect approximately 100,000 individuals in the United States. Consistent with the ",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    }
  ],
  "diseases": [
    {
      "name": "acquired generalized lipodystrophy",
      "matched_text": "acquired generalized lipodystrophy",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": "Orphanet:79086"
    },
    {
      "name": "acquired partial lipodystrophy",
      "matched_text": "acquired partial lipodystrophy",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": "Orphanet:79087"
    },
    {
      "name": "barraquer-simons syndrome",
      "matched_text": "Barraquer-Simons syndrome",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": null
    },
    {
      "name": "localized lipodystrophy",
      "matched_text": "localized lipodystrophy",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": "Orphanet:79088"
    },
    {
      "name": "acquired lipodystrophy",
      "matched_text": "Acquired lipodystrophies",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": "Orphanet:98307"
    },
    {
      "name": "hypertriglyceridemia",
      "matched_text": "hypertriglyceridemia",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": null
    },
    {
      "name": "glucose intolerance",
      "matched_text": "glucose intolerance",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": null
    },
    {
      "name": "lipodystrophy",
      "matched_text": "lipodystrophy",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare": false,
      "icd10": null,
      "orpha": null
    },
    {
      "name": "fatty liver",
      "matched_text": "fatty liver",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": null
    },
    {
      "name": "diabetes",
      "matched_text": "diabetes",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": "ICD10CM:E08-E13",
      "orpha": null
    },
    {
      "name": "APL",
      "matched_text": "APL",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": "ICD10CM:C92.4",
      "orpha": "Orphanet:520"
    }
  ],
  "drugs": [
    {
      "name": "Insulin",
      "matched_text": "insulin",
      "compound_id": null,
      "confidence": 0.85,
      "is_investigational": true,
      "phase": "ACTIVE_NOT_RECRUITING"
    },
    {
      "name": "TRIGLYCERIDES",
      "matched_text": "triglycerides",
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "phase": null
    }
  ],
  "pharma": []
}